(1)
Boucenna, A.; Hirech, A.; Larbi, R. M.; Satta, D. Impact of CYP2D6 Polymorphisms in Predicting Occurrence of Adverse Effect to Tamoxifen and Developing Recurrence in ER+ Breast Cancer Patients. Arch Breast Cancer 2024, 11.